QuickView for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=161EA4FB6A70DC430F4519468CC7F620;jsessionid=696890CAB45EBF2E3C87D2130F1D510F;jsessionid=2ABB7ED683E2DFC0A690617E0F907157;jsessionid=8A88A6C9211312A1A826198A60F9D412;jsessionid=D0D31B017D94F9C141A0245BB3A5E568;jsessionid=2A50AE0BB6880FC42606F2CA8A30F820;jsessionid=BA5865B14E9D08846705BC0841CB904F;jsessionid=1C967964ABD6C984065E8B9EA0E91709 (gene)

1. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
2. Clinical Evaluation of Cystic Renal Masses With Bosniak Classification by Contrast-Enhanced Ultrasou…
3. Feasibility of Surveillance for Mucinous Cystic Neoplasm of the Pancreas: A Multi-Institutional Retr…
4. Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lun…
5. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal mas…

There were no clinical trials for YDL103C;jsessionid=15F15BB478DC6C77651BC16CE76A6F8A;jsessionid=FA09DD4A5D65571BA1AD979499E356E2;jsessionid=5DB5107377C50D220B2B02849FAC3A0E;jsessionid=161EA4FB6A70DC430F4519468CC7F620;jsessionid=696890CAB45EBF2E3C87D2130F1D510F;jsessionid=2ABB7ED683E2DFC0A690617E0F907157;jsessionid=8A88A6C9211312A1A826198A60F9D412;jsessionid=D0D31B017D94F9C141A0245BB3A5E568;jsessionid=2A50AE0BB6880FC42606F2CA8A30F820;jsessionid=BA5865B14E9D08846705BC0841CB904F;jsessionid=1C967964ABD6C984065E8B9EA0E91709